Market Access Strategy and Analytics

Effectively executing your market access strategy is critical to the success of your brand. Real-world data provides the visibility, but the capacity to translate complex market dynamics into actionable insights requires deep analytical skill and expertise.
Contact Us

Build and execute a more successful market access strategy. 

Partner with IQVIA to navigate today’s increasingly challenging payer environment and maximize profitability across the full lifecycle of your product. Data-driven insights on payer, provider, and patient behavior position our market-leadings strategists to execute the analyses you need. Make more informed and effective decisions for today’s landscape with best-in-class evaluations, models, forecasts and simulations.

  • Develop and implement strategies that maximize both access and the gross-to-net value of your products, by partnering with the skilled, forward-thinking team of consultants from our Amundsen Consulting division.
  • Leverage a foundation of industry-leading data and syndicated analytics solutions specific to managed markets to inform more effective strategy and respond with agility to evolving market trends.
  • Understand the influence of Integrated Delivery Networks (IDNs) on your market access strategy. IQVIA offers deep insights into the control of IDNs on prescribing behavior as well as rich profile information detailing the need-to-know characteristics of the organizations that make up these networks.
Contact us.
Market Access Strategy and Analytics Solutions
Amundsen Consulting

Rely on market-leading strategists to help you achieve maximum access and profitability

IDN Insights

Design and execute an informed IDN strategy.

Managed Markets Data & Analytic Solutions

Inform your access strategy with critical insights into payer, provider and patient behavior.

Related Solutions
Contract Operations

Improve your contract and revenue management

Patient Affordability and Engagement Solutions

Increase patient access and adherence.